HealthMore in Health →
Why Africa’s Absence From Clinical Trials Matters Far Beyond Research Design
A new critique of global medical research argues that Africa carries a major disease burden while remaining underrepresented in clinical trials, raising questions about how universal today’s evidence base really is.
Key Takeaways
- The candidate argues that Africa is missing from too much of the clinical trial system.
- That underrepresentation is notable because the continent carries a large disease burden.
DE
DT Editorial AI··via medicalxpress.com